kennzo

SWTX (SpringWorks Therapeutics) - Bullish end to Quarter

Long
NASDAQ:SWTX   SpringWorks Therapeutics, Inc
SPRINGWORKS THERAPEUTICS INC.

SpringWorks Therapeutics Inc . is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc . is based in Stamford, United States.

Analysis/Commentary
New business, so lots of unknowns, but potential to the upside

Based on the study of the previous quarterly earnings reports and subsequent price moves:
- Current quarter has given price move below LOW point
- Buy opportunity in place
- Expectation for the price to move back to LOW or MID point
- Trailing stop-loss on price above LOW point

GOOD LUCK.
DO YOUR OWN RESEARCH!
Comment: TRADE UPDATE: Neutral to date
Hold to quarter end for potential break-even